These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 23955801)

  • 1. Lack of association of EPHX1 gene polymorphisms with risk of hepatocellular carcinoma: a meta-analysis.
    Duan CY; Liu MY; Li SB; Ma KS; Bie P
    Tumour Biol; 2014 Jan; 35(1):659-66. PubMed ID: 23955801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of association of two common polymorphisms rs2910164 and rs11614913 with susceptibility to hepatocellular carcinoma: a meta-analysis.
    Wang Z; Cao Y; Jiang C; Yang G; Wu J; Ding Y
    PLoS One; 2012; 7(6):e40039. PubMed ID: 22768213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between microsomal epoxide hydrolase 1 polymorphisms and susceptibility to esophageal cancer: a meta-analysis.
    Zhao W; Luo J; Cai X
    Tumour Biol; 2013 Aug; 34(4):2383-8. PubMed ID: 23681797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of association of MiR-34b/c polymorphism (rs4938723) with hepatocellular carcinoma: a meta-analysis.
    Liang TJ; Liu HJ; Zhao XQ; Yu CH; Li CS
    PLoS One; 2013; 8(7):e68588. PubMed ID: 23935875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenase-2 gene polymorphisms and susceptibility to hepatocellular carcinoma: A meta-analysis based on 10 case-control studies.
    Xu W; Huang Y; Zhang T; Zhao L; Fan J; Li L
    J Cancer Res Ther; 2018; 14(Supplement):S105-S113. PubMed ID: 29578159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of microsomal epoxide hydrolase gene polymorphism and risk of hepatocellular carcinoma.
    Zhong JH; Xiang BD; Ma L; You XM; Li LQ; Xie GS
    PLoS One; 2013; 8(2):e57064. PubMed ID: 23451147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [EPHX1 Tyr113His polymorphism contributes to hepatocellular carcinoma risk: evidfnce from a meta-analysis].
    Wang D; Zhai JX; Zhang LM; Liu DW; Liu XH
    Mol Biol (Mosk); 2015; 49(2):351-61. PubMed ID: 26065263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review and meta-analysis of the relationship between EPHX1 polymorphisms and colorectal cancer risk.
    Liu F; Yuan D; Wei Y; Wang W; Yan L; Wen T; Xu M; Yang J; Li B
    PLoS One; 2012; 7(8):e43821. PubMed ID: 22928041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. XPD Polymorphisms and Risk of Hepatocellular Carcinoma and Gastric Cancer: A Meta-Analysis.
    Zhou Q; Fu Y; Wen L; Deng Y; Chen J; Liu K
    Technol Cancer Res Treat; 2021; 20():1533033821990046. PubMed ID: 33517857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative assessment of the influence of EPHX1 gene polymorphisms and cancer risk: a meta-analysis with 94,213 subjects.
    Yang X; Wang Y; Wang G
    J Exp Clin Cancer Res; 2014 Sep; 33(1):82. PubMed ID: 25261893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of association between EPHX1 polymorphism and esophageal cancer risk: evidence from meta-analysis.
    Yan YL; Chen X; Liang HJ; Wang J; Li TJ; Li RL; Li S; Qin X
    Dis Esophagus; 2015; 28(2):164-71. PubMed ID: 25714851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between rs738409 polymorphism in patatin-like phospholipase domain-containing protein 3 (PNPLA3) gene and hepatocellular carcinoma susceptibility: Evidence from case-control studies.
    Li JF; Zheng EQ; Xie M
    Gene; 2019 Feb; 685():143-148. PubMed ID: 30403964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. X-ray repair cross-complementing group 1 polymorphisms and hepatocellular carcinoma: a meta-analysis.
    Xie T; Wang ZG; Zhang JL; Liu H
    World J Gastroenterol; 2012 Aug; 18(31):4207-14. PubMed ID: 22919255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative assessment of the effects of the EPHX1 Tyr113His polymorphism on lung and breast cancer.
    Tan X; Wang YY; Chen XY; Xian L; Guo JJ; Liang GB; Chen MW
    Genet Mol Res; 2014 Sep; 13(3):7437-46. PubMed ID: 25222243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between esophageal cancer risk and EPHX1 polymorphisms: a meta-analysis.
    Li QT; Kang W; Wang M; Yang J; Zuo Y; Zhang W; Su DK
    World J Gastroenterol; 2014 May; 20(17):5124-30. PubMed ID: 24803829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between microsomal epoxide hydrolase 1 T113C polymorphism and susceptibility to lung cancer.
    Wang S; Zhu J; Zhang R; Wang S; Gu Z
    Tumour Biol; 2013 Apr; 34(2):1045-52. PubMed ID: 23378225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of interleukin-6 gene polymorphisms with the risk of hepatocellular carcinoma: An up-to-date meta-analysis.
    An PP; Feng LN; Zhang XX; Jin QL
    Medicine (Baltimore); 2020 Dec; 99(50):e23659. PubMed ID: 33327352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between polymorphisms of microsomal epoxide hydrolase and COPD: results from meta-analyses.
    Hu G; Shi Z; Hu J; Zou G; Peng G; Ran P
    Respirology; 2008 Nov; 13(6):837-50. PubMed ID: 18811882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between Cox-2 rs20417 and rs5275 polymorphisms and the risk of hepatocellular carcinoma: a meta analysis.
    Wu H; Wu X; Wan G; Zhang S
    Int J Clin Exp Pathol; 2014; 7(10):6898-905. PubMed ID: 25400773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis demonstrates lack of a relationship between XRCC1-399 gene polymorphisms and susceptibility to hepatocellular carcinoma.
    Zeng XY; Huang JM; Xu JW; Xu Y; Yu HP; Ji L; Qiu XQ
    Genet Mol Res; 2013 Jun; 12(2):1916-23. PubMed ID: 23546985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.